Stay up to date on the latest oncology and nursing conferences.
Oral Chemotherapy Adherence: Monitoring for Better Outcomes
May 9th 2016In an effort to help ensure that patients are taking their oral anticancer medications and refilling their prescriptions, a team of four nurses and a physician from NYU Langone’s Laura & Isaac Perlmutter Cancer Center integrated a novel tracking workflow documentation system into the electronic health record.
Nurse-Led Resource Center Offers Precision Medicine Support for Patients and Families
May 5th 2016With genetic profiles and genomic targeting increasingly impacting treatment decisions, patients and families would welcome a one-stop place where they can find resources to help unravel all this complex information.
Moving Proactively to Support Patients With EGFR Inhibitor-Related Dermatologic AEs
May 1st 2016Developing a skin rash as a result of EGFR-inhibitor targeted therapy often signals that the drug is working, but for patients who experience these serious dermatologic adverse events, it may become so intolerable that they will scale back or even discontinue anticancer medications that could prolong their survival.
Oncology Nurses Poised to Make a Difference in Managing "Silent" Portal Vein Thrombosis
April 30th 2016Portal vein thrombosis (PVT) is a dangerous and often overlooked side effect of certain gastrointestinal malignancies such as liver and pancreatic cancer, that oncology nurses need to be more proactive in managing.
Moving Time-Consuming Chemo Regimens to Outpatient Settings Better for Patients
April 30th 2016When chemotherapy involves tricky infusion timing, patients are routinely admitted to hospitals to receive their treatments. But what would happen if these drugs could be administered successfully on an outpatient basis?
When a Symptom Intervention Works, Why Not Use It?
April 29th 2016When oncology nurses move proactively to learn more about and use proven effective “green-lighted” interventions like exercise and muscle relaxation in their daily practice, it can go a long way in helping patients and their caregivers manage symptoms associated with a cancer diagnosis like fatigue and anxiety.
Nurse-Led Study Evaluates Safe Use of Nephrostomy Tube to Deliver Chemotherapy and Biotherapy
April 29th 2016Researchers at the Rutgers Cancer Institute of New Jersey are testing the possibility of sending treatment drugs directly to the kidney in patients with upper urinary tract urothelial carcinoma in situ or small tumors in the kidney area.
Ellyn Matthews Addresses Misconceptions About Sleep Disturbances
April 28th 2016Ellyn Matthews, PhD, RN, AOCNS, CBSM, who holds the Elizabeth Stanley Cooper Endowed Chair in Oncology Nursing at the University of Arkansas for Medical Sciences, addresses common misconceptions that patients with cancer have about sleep disturbances.
41st ONS Congress Showcases Resources and Insights for Today's Oncology Nurse
April 28th 2016A team of editors from Oncology Nursing News and CURE magazine will be in San Antonio at the 41st Annual ONS Congress covering sessions and interviewing nurses about their research of interest to oncology professionals and to the patients and survivors they tweet.
Abdominal Radiation May Increase Diabetes Risk in Childhood Cancer Survivors
January 20th 2016Previous studies have linked radiation to the pancreas during childhood to an increased risk of type 1 or 2 diabetes, and in a recent small study, researchers investigated the mechanisms leading to abnormal glucose and insulin dynamics in survivors of childhood cancers.
Weight-Loss Intervention Improves Fitness in Cancer Survivors
January 19th 2016Mounting research continues to show increased risk of cancer recurrence and death in obese individuals, but findings of a new study highlight the benefits of weight-loss interventions for overweight and obese cancer survivors.
Addressing Cisplatin's Late Effects in Testicular Cancer Survivors
January 16th 2016New research shows that survivors of testicular cancer may have an increased burden of morbidity after being treated with cisplatin-based chemotherapy, with obesity, neuropathies, and tinnitus and hearing loss among the most prevalent late effects.
Complete Guideline Adherence Low Among Young Hodgkin Lymphoma Survivors
January 12th 2016Despite national evidence- and consensus-based guidelines on posttreatment care, less than half of adolescents and young adults (AYAs) with Hodgkin lymphoma receive all of the recommended services within the first year after treatment, according to results of a pilot study being presented at the 2016 Cancer Survivorship Symposium.